Invensense - der Wearable Computer Profiteur?
| eröffnet am: | 04.11.13 12:44 von: | Spreeblick |
| neuester Beitrag: | 22.01.14 12:12 von: | Ember |
| Anzahl Beiträge: | 9 | |
| Leser gesamt: | 5209 | |
| davon Heute: | 1 | |
bewertet mit 1 Stern |
||
|
|
||
04.11.13 12:44
#1
Spreeblick
Invensense - der Wearable Computer Profiteur?
Bin auf die Aktie von Invensense gestoßen, der Marktführer für den Markt der Bewegungssensor-Chips. Die Firma aus Kalifornien (direkt um die Ecke von Apple) ist derzeit unter anderem in den Nintendo Konsolen vertreten und viel interessanter ist die Marktvermutung, dass Invensense Chips in der Apple "iWatch" enthalten sind. Ein gigantischer Markt, der sich da erschließt. Es wird angenommen, dass die iWatch im Jahr 2014 erscheinen wird. Zumindest deuten die zuletzt getätigten Personalien bei Apple darauf hin, dass die iWatch auch tatsächlich ein interessantes Produkt werden kann, nicht nur von der Funktionalität, sondern auch vom Design.
Auf jeden Fall einen Blick wert, scheint hierzulande noch nicht so auf dem Radar zu sein. Bei MotleyFool wird diese Aktie gerade als hochinteressant gehandelt.
Hier die Website von Invensense:
http://www.invensense.com/
Weitere aktuelle News:
http://www.ciol.com/ciol/news/199926/...ed-google-s-android-kitkat-44
http://www.fool.com/investing/general/2013/11/01/...nit-to-inven.aspx
Interview mit dem CEO. Seine Reaktion bei der Apple Frage finde ich interessant. Das Lächeln im Gesicht finde ich zumindest interessant.
http://video.cnbc.com/gallery/?play=1&video=3000213346
Auf jeden Fall einen Blick wert, scheint hierzulande noch nicht so auf dem Radar zu sein. Bei MotleyFool wird diese Aktie gerade als hochinteressant gehandelt.
Hier die Website von Invensense:
http://www.invensense.com/
Weitere aktuelle News:
http://www.ciol.com/ciol/news/199926/...ed-google-s-android-kitkat-44
http://www.fool.com/investing/general/2013/11/01/...nit-to-inven.aspx
Interview mit dem CEO. Seine Reaktion bei der Apple Frage finde ich interessant. Das Lächeln im Gesicht finde ich zumindest interessant.
http://video.cnbc.com/gallery/?play=1&video=3000213346
04.11.13 13:36
#2
Spreeblick
eine interessante Analyse
Ein interessanter Artikel dazu auch auf SeekingAlpha:
http://seekingalpha.com/article/...m-invensense-in-2014?source=nasdaq
http://seekingalpha.com/article/...m-invensense-in-2014?source=nasdaq
05.11.13 22:17
#3
Spreeblick
Invensense platziert 125 Mio. $ Wandelanleihe
nvenSense To Offer $125 Million Convertible Senior Notes Due 2018
Thomson Reuters ONEPress Release: InvenSense, Inc. – 10 minutes ago
SAN JOSE, California, November 5, 2013 - InvenSense, Inc. (INVN), the leading provider of MotionTracking(TM) system on chip devices, today announced its intention to offer, subject to market and other conditions, $125 million aggregate principal amount of convertible senior notes due 2018 (the "notes") in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). InvenSense also expects to grant the initial purchaser of the notes an option to purchase up to an additional $18.75 million aggregate principal amount of the notes.
The notes will be unsecured, senior obligations of InvenSense, and interest will be payable semi-annually. Prior to August 1, 2018, the notes will be convertible only upon the occurrence of specified events; thereafter, until maturity on November 1, 2018, the notes will be convertible at any time. Upon conversion, the notes will be settled in cash up to the aggregate principal amount of the notes to be converted, and any excess conversion value will be convertible into cash, shares of common stock or a combination of cash and shares of common stock, at InvenSense`s election. Final terms of the notes, including the interest rate, initial conversion rate and other terms, will be determined by negotiations between InvenSense and the initial purchaser of the notes.
In connection with the pricing of the notes, InvenSense expects to enter into privately negotiated convertible note hedge transactions with the initial purchaser or an affiliate thereof (the "hedge counterparty"). The convertible note hedge transactions are generally expected to reduce the potential dilution and/or offset the cash payments InvenSense is required to make in excess of the principal amount upon conversion of the notes, in the event that the market price of InvenSense`s common stock is greater than the strike price of the convertible note hedge transactions. InvenSense also expects to enter into privately negotiated warrant transactions with the hedge counterparty, and anticipates that the warrants will have an exercise price that is approximately 80% higher than the closing price of InvenSense`s common stock on the date the warrants are issued. The warrant transactions could separately have a dilutive effect if the market price of InvenSense`s common stock exceeds the strike price of the warrant transactions, unless InvenSense elects, subject to certain conditions, to settle the warrant transactions in cash. If the initial purchaser exercises its option to purchase additional notes, InvenSense may enter into additional convertible note hedge transactions and additional warrant transactions with the hedge counterparty. InvenSense has been advised that, in connection with hedging the convertible note hedge transactions and warrant transactions, the hedge counterparty or its affiliate may enter into various derivative transactions concurrently with, or shortly after, the pricing of the notes. These activities could have the effect of increasing, or preventing a decline (or reducing the size of any decline) in, the market price of InvenSense`s common stock concurrently with, or shortly after, the pricing of the notes. In addition, InvenSense has been advised by the hedge counterparty that the hedge counterparty or its affiliate may modify its hedge positions by entering into or unwinding various derivative transactions with respect to InvenSense`s common stock and/or purchasing or selling InvenSense`s common stock or other securities of InvenSense in secondary market transactions following the pricing of the notes and prior to the maturity of the notes (and are likely to do so during any observation period related to a conversion of the notes). This activity could also have the effect of increasing, or preventing a decline (or reducing the size of any decline) in, the market price of InvenSense`s common stock, which could affect the ability of noteholders to convert the notes and, to the extent the activity occurs during any observation period related to a conversion of the notes, could affect the amount and value of the consideration that noteholders will receive upon conversion of the notes. The convertible note hedge transactions and warrant transactions have not been, and will not be, registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States without registration or an applicable exemption from registration requirements.
InvenSense intends to use a portion of the net proceeds for the cost of the convertible note hedge transactions after such cost is partially offset by the proceeds of the warrant transactions described above, and to use the remaining proceeds for general corporate purposes, including capital expenditures and working capital.
Goldman, Sachs & Co. will act as the sole initial purchaser for resale of the offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act.
Thomson Reuters ONEPress Release: InvenSense, Inc. – 10 minutes ago
SAN JOSE, California, November 5, 2013 - InvenSense, Inc. (INVN), the leading provider of MotionTracking(TM) system on chip devices, today announced its intention to offer, subject to market and other conditions, $125 million aggregate principal amount of convertible senior notes due 2018 (the "notes") in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). InvenSense also expects to grant the initial purchaser of the notes an option to purchase up to an additional $18.75 million aggregate principal amount of the notes.
The notes will be unsecured, senior obligations of InvenSense, and interest will be payable semi-annually. Prior to August 1, 2018, the notes will be convertible only upon the occurrence of specified events; thereafter, until maturity on November 1, 2018, the notes will be convertible at any time. Upon conversion, the notes will be settled in cash up to the aggregate principal amount of the notes to be converted, and any excess conversion value will be convertible into cash, shares of common stock or a combination of cash and shares of common stock, at InvenSense`s election. Final terms of the notes, including the interest rate, initial conversion rate and other terms, will be determined by negotiations between InvenSense and the initial purchaser of the notes.
In connection with the pricing of the notes, InvenSense expects to enter into privately negotiated convertible note hedge transactions with the initial purchaser or an affiliate thereof (the "hedge counterparty"). The convertible note hedge transactions are generally expected to reduce the potential dilution and/or offset the cash payments InvenSense is required to make in excess of the principal amount upon conversion of the notes, in the event that the market price of InvenSense`s common stock is greater than the strike price of the convertible note hedge transactions. InvenSense also expects to enter into privately negotiated warrant transactions with the hedge counterparty, and anticipates that the warrants will have an exercise price that is approximately 80% higher than the closing price of InvenSense`s common stock on the date the warrants are issued. The warrant transactions could separately have a dilutive effect if the market price of InvenSense`s common stock exceeds the strike price of the warrant transactions, unless InvenSense elects, subject to certain conditions, to settle the warrant transactions in cash. If the initial purchaser exercises its option to purchase additional notes, InvenSense may enter into additional convertible note hedge transactions and additional warrant transactions with the hedge counterparty. InvenSense has been advised that, in connection with hedging the convertible note hedge transactions and warrant transactions, the hedge counterparty or its affiliate may enter into various derivative transactions concurrently with, or shortly after, the pricing of the notes. These activities could have the effect of increasing, or preventing a decline (or reducing the size of any decline) in, the market price of InvenSense`s common stock concurrently with, or shortly after, the pricing of the notes. In addition, InvenSense has been advised by the hedge counterparty that the hedge counterparty or its affiliate may modify its hedge positions by entering into or unwinding various derivative transactions with respect to InvenSense`s common stock and/or purchasing or selling InvenSense`s common stock or other securities of InvenSense in secondary market transactions following the pricing of the notes and prior to the maturity of the notes (and are likely to do so during any observation period related to a conversion of the notes). This activity could also have the effect of increasing, or preventing a decline (or reducing the size of any decline) in, the market price of InvenSense`s common stock, which could affect the ability of noteholders to convert the notes and, to the extent the activity occurs during any observation period related to a conversion of the notes, could affect the amount and value of the consideration that noteholders will receive upon conversion of the notes. The convertible note hedge transactions and warrant transactions have not been, and will not be, registered under the Securities Act or the securities laws of any other jurisdiction and may not be offered or sold in the United States without registration or an applicable exemption from registration requirements.
InvenSense intends to use a portion of the net proceeds for the cost of the convertible note hedge transactions after such cost is partially offset by the proceeds of the warrant transactions described above, and to use the remaining proceeds for general corporate purposes, including capital expenditures and working capital.
Goldman, Sachs & Co. will act as the sole initial purchaser for resale of the offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act.
06.11.13 10:59
#4
Spreeblick
zur Wandelanleihe
Es sieht also so aus, als wenn Invensense ordentlich was vorhat und jetzt noch schneller expandieren wird. Entweder gibt es Fortschritte bei der iWatch oder ein anderer großer Kunde ist an der Angel und dafür muss nun ordentlich investiert werden.
Mit der Wandelanleihe werden die Zinsen niedrig gehalten. Sollten die Anleiheinhaber in Aktien umwandeln wollen, dann müssten zwar mehr Aktien ausgegeben werden, was natürlich zu einer Verwässerung führt, aber laut INVN gibt es gegen die Verwässerung bereits eine Hedge Strategie.
Bin echt gespannt, wann die Bombe platzt...
Mit der Wandelanleihe werden die Zinsen niedrig gehalten. Sollten die Anleiheinhaber in Aktien umwandeln wollen, dann müssten zwar mehr Aktien ausgegeben werden, was natürlich zu einer Verwässerung führt, aber laut INVN gibt es gegen die Verwässerung bereits eine Hedge Strategie.
Bin echt gespannt, wann die Bombe platzt...
11.11.13 21:21
#5
Spreeblick
Piper Jaffray erhöht Kursziel auf $25.00
Piper Jaffray Reiterates on InvenSense on More Growth Factors Than a Hormone Factory
Dwight Einhorn, Benzinga Staff Writer
In a report published Monday, Piper Jaffray analyst Auguste Gus Richard reiterated an Overweight rating and $25.00 price target on InvenSense (NYSE: INVN [FREE Stock Trend Analysis]).
In the report, Piper Jaffray noted, “We see a number of growth catalysts for INVN over the next two years. They include increasing penetration at Samsung, growing optical image stability penetration, the addition of Apple as a customer, wearables, penetration in low-end smartphones and growth in MEMS microphones. In addition, the company is increasing its value proposition through the integration of additional sensors and increasing software content. We believe the combination of higher levels of integration and more software content will offset normal price erosion in the high volume mobile market. This should allow the company to grow revenue in the 25%-35% range while maintaining gross margin. Finally, we see near term catalysts over the next 90 days as we expect new product announcements at CES and Mobile World Congress as well as a number of wearable design wins. Reiterate OW and $25 PT.”
Read more: http://www.benzinga.com/analyst-ratings/...re-growth-fa#ixzz2kN1Kyg5f
Dwight Einhorn, Benzinga Staff Writer
In a report published Monday, Piper Jaffray analyst Auguste Gus Richard reiterated an Overweight rating and $25.00 price target on InvenSense (NYSE: INVN [FREE Stock Trend Analysis]).
In the report, Piper Jaffray noted, “We see a number of growth catalysts for INVN over the next two years. They include increasing penetration at Samsung, growing optical image stability penetration, the addition of Apple as a customer, wearables, penetration in low-end smartphones and growth in MEMS microphones. In addition, the company is increasing its value proposition through the integration of additional sensors and increasing software content. We believe the combination of higher levels of integration and more software content will offset normal price erosion in the high volume mobile market. This should allow the company to grow revenue in the 25%-35% range while maintaining gross margin. Finally, we see near term catalysts over the next 90 days as we expect new product announcements at CES and Mobile World Congress as well as a number of wearable design wins. Reiterate OW and $25 PT.”
Read more: http://www.benzinga.com/analyst-ratings/...re-growth-fa#ixzz2kN1Kyg5f
13.11.13 20:14
#6
Spreeblick
+ 5% auf Nasdaq
Sehr positive Stimmung heute. Es wird erwartet, dass Inversense demnächst mit Nachrichten aufwarten kann, dass sie bei Apple mit drin sind. Das würde den Kurs natrülich ordentlich nach oben katapultieren.
Mit dem Kauf der ADI Mikrofonsparte wurde noch weiter diversifiziert und die wurden bis vor kurzem auch noch in Apple eingesetzt.
Ist auf jeden Fall ein sehr interessantes Long Investment mit ordentlich Steigerungspotential.
Verstehe gar nicht, dass die Aktie hier im Ariva Forum gar keine Aufmerksamkeit hat.
Mit dem Kauf der ADI Mikrofonsparte wurde noch weiter diversifiziert und die wurden bis vor kurzem auch noch in Apple eingesetzt.
Ist auf jeden Fall ein sehr interessantes Long Investment mit ordentlich Steigerungspotential.
Verstehe gar nicht, dass die Aktie hier im Ariva Forum gar keine Aufmerksamkeit hat.
22.01.14 12:12
#9
Ember
Invensense jetzt einsteigen?
Ich überlege einzusteigen, aber überlege, weil ich glaube, dass ziemlich bald eine heftige Börsenkorrektur kommt. Ist nur die Frage, ob Invensense davon nicht so stark betroffen sein wird...